Papillary Thyroid Carcinoma Survival Rate

Aug 10, 2021 Source: Cainiu Health
Dr. Zhang Jun
Introduction
Papillary thyroid carcinoma is a relatively low-grade malignancy, and thus patients generally have a high survival rate. However, it should not be taken lightly, as it is, after all, a form of cancer with a non-negligible mortality risk. Currently, in China’s medical community, there is no definitive answer regarding the exact survival duration for patients with papillary thyroid carcinoma, as survival time depends on numerous factors.

Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Currently, its incidence is very high, and an increasing number of people are being diagnosed with this disease in daily life. PTC poses significant health risks, warranting serious attention. Upon diagnosis, patients should promptly seek standardized, effective medical treatment at a hospital.

1 (1)_副本1.jpg

Survival Rate for Papillary Thyroid Carcinoma

Papillary thyroid carcinoma is relatively low-grade malignancy, resulting in a comparatively high survival rate. Nevertheless, it must not be taken lightly—as a form of cancer, it still carries a certain mortality risk. At present, Chinese medicine cannot provide a definitive answer regarding the exact survival duration for PTC patients, as numerous factors influence prognosis. These include the patient’s overall physical condition, the level of understanding—by both the patient and their family—regarding PTC treatment options, and the specific treatment strategy selected. Therefore, close communication with physicians throughout treatment is essential.

4 (1)_副本1.jpg

Additional Information: Treatment Options for Papillary Thyroid Carcinoma

1. Surgical Treatment

Surgical resection is the primary treatment for papillary thyroid carcinoma. The surgical approach depends on the extent of the tumor: either unilateral lobectomy plus isthmusectomy or total thyroidectomy. Additionally, central compartment lymph node dissection or comprehensive cervical lymph node dissection is performed based on the presence and extent of cervical lymph node metastasis.

2. Hormone Therapy

Thyroid hormone therapy suppresses serum thyroid-stimulating hormone (TSH), which otherwise promotes the growth of thyroid cancer cells. Thus, this therapy helps eliminate the hormonal environment conducive to tumor progression, achieving therapeutic goals. Moreover, radioactive iodine (RAI) therapy is indicated for advanced cases with pulmonary or osseous metastases, as well as for select high-risk patients.

0_副本1.jpg

The above outlines key information regarding the survival rate of papillary thyroid carcinoma. We hope this content proves helpful to you.

Related Articles

View All